ACORN CAPITAL ADVISORS, LLC
NEW YORK, NY · CIK 2054410 · 13F filing filed 2026-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyNew York, NY
$366.5m
reported value
+4.2% vs Q1 2026
20positions
90.2%in top 10
1 new
5 added
3 reduced
3 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CG ONCOLOGY INC CGON | $80.4m21.94% | Added +999 |
| UROGEN PHARMA LTD URGN | $61.6m16.80% | Unchanged |
| TREVI THERAPEUTICS INC TRVI | $40.0m10.92% | Unchanged |
| CANDEL THERAPEUTICS INC CADL | $36.0m9.83% | Unchanged |
| PUMA BIOTECHNOLOGY INC PBYI | $33.5m9.14% | Unchanged |
| JADE BIOSCIENCES INC JBIO | $21.9m5.98% | Added +200.0k |
| BICARA THERAPEUTICS INC BCAX | $19.1m5.21% | Reduced -1 |
| KARYOPHARM THERAPEUTICS INC KPTI | $14.8m4.05% | Added +1.2m |
| ONKURE THERAPEUTICS INC OKUR | $12.9m3.53% | Unchanged |
| CYBIN INC COM NEW | $10.2m2.78% | Unchanged |
| PROTARA THERAPEUTICS INC TARA | $6.7m1.83% | Unchanged |
| AURA BIOSCIENCES INC AURA | $6.6m1.80% | Added +333.3k |
| LEONABIO INC LONA | $5.8m1.59% | Unchanged |
| VERASTEM INC VSTM | $5.6m1.53% | Unchanged |
| AADI BIOSCIENCE INC WHWK | $5.2m1.42% | Unchanged |
| Q32 BIO INC QTTB | $2.8m0.75% | Reduced -98.9k |
| ENGENE THERAPEUTICS INC ENGN | $2.2m0.60% | New |
| JASPER THERAPEUTICS INC JSPR | $604.0k0.16% | Added +26.7k |
| BIOATLA INC BCAB | $447.6k0.12% | Reduced -5.3m |
| VYNE THERAPEUTICS INC COM | $9260.00% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| TERNS PHARMACEUTICALS INC | $92.1m1.7m shares |
| CARDIFF ONCOLOGY INC CRDF | $2.9m1.8m shares |
| X4 PHARMACEUTICALS INC | $966.6k234.0k shares |